Singapore markets close in 4 hours 2 minutes
Straits Times Index
3,325.37 -0.91 (-0.03%) Nikkei
39,646.88 +473.73 (+1.21%) Hang Seng
18,069.75 -3.15 (-0.02%) FTSE 100
8,247.79 -33.76 (-0.41%) Bitcoin USD
61,725.30 +371.96 (+0.61%) CMC Crypto 200
1,280.77 +31.64 (+2.53%)
BCYC Sep 2024 25.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:12AM EDT. Market open.
| Previous close | 2.5000 |
| Open | 2.5000 |
| Bid | 1.0000 |
| Ask | 5.0000 |
| Strike | 25.00 |
| Expiry date | 2024-09-20 |
| Day's range | 2.5000 - 2.5000 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
ZacksTop 5 Small-Cap Biotechnology Stocks for a Stable Portfolio
We have narrowed our search to five small-cap biotech stocks with strong potential for the rest of 2024. These are: ARQT, BCYC, CSTL, PRME, LXRX.
ZacksIs Bicycle Therapeutics (BCYC) Stock Outpacing Its Medical Peers This Year?
Here is how Bicycle Therapeutics PLC Sponsored ADR (BCYC) and Brookdale Senior Living (BKD) have performed compared to their sector so far this year.
- Business Wire
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
CAMBRIDGE, England & BOSTON, June 03, 2024--Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that management will participate in the following investor conferences in June:
© 2024 Yahoo. All rights reserved.